These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 16049563

  • 21. Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy.
    Xu Q, Liu R, Wang J, Huang Y, Li S, Zhang L, Wang F.
    Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
    [Abstract] [Full Text] [Related]

  • 22. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G, Possa M, Sara R, Milella M, Rossetti C.
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [Abstract] [Full Text] [Related]

  • 23. Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma.
    Giovanella L, Suriano S, Castellani M, Ceriani L, Verburg FA.
    Clin Nucl Med; 2011 Sep; 36(9):781-5. PubMed ID: 21825849
    [Abstract] [Full Text] [Related]

  • 24. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
    Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Flores LG, Watanabe K.
    J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
    [Abstract] [Full Text] [Related]

  • 25. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
    Miyamoto S, Kasagi K, Misaki T, Alam MS, Konishi J.
    J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
    [Abstract] [Full Text] [Related]

  • 27. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 28. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation.
    Alam MS, Kasagi K, Misaki T, Miyamoto S, Iwata M, Iida Y, Konishi J.
    Thyroid; 1998 Dec; 8(12):1091-100. PubMed ID: 9920363
    [Abstract] [Full Text] [Related]

  • 29. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 30. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
    Pachón-Garrudo VM, Cuenca-Cuenca JI, Ruiz-Franco-Baux J, Borrego-Dorado I, Tirado-Hospital JL, Navarro-González E, Vázquez-Albertino R.
    Rev Esp Med Nucl Imagen Mol; 2012 Jul; 31(6):315-21. PubMed ID: 23084014
    [Abstract] [Full Text] [Related]

  • 31. The Value of 99mTc-MIBI SPECT/CT in the Postoperative Assessment of Patients with Differentiated Thyroid Carcinoma.
    Okudan B, Seven B, Gülaldı NCM, Çapraz M, Açıkgöz Y.
    Curr Med Imaging; 2022 Jul; 18(4):404-408. PubMed ID: 34749623
    [Abstract] [Full Text] [Related]

  • 32. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H.
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [Abstract] [Full Text] [Related]

  • 33. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma.
    Boz A, Arici C, Güngör F, Yildiz A, Colak T, Karayalçin B.
    Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916
    [Abstract] [Full Text] [Related]

  • 34. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer.
    Campennì A, Violi MA, Ruggeri RM, Sindoni A, Moleti M, Vermiglio F, Baldari S.
    Nucl Med Commun; 2010 Apr; 31(4):274-9. PubMed ID: 20087239
    [Abstract] [Full Text] [Related]

  • 35. Role of technetium-99m sestamibi in localisation of thyroid cancer metastases.
    Sundram FX, Goh AS, Ang ES.
    Ann Acad Med Singap; 1993 Jul; 22(4):557-9. PubMed ID: 8257057
    [Abstract] [Full Text] [Related]

  • 36. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
    Küçük ON, Aras G, Kulak HA, Ibiş E.
    Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
    [Abstract] [Full Text] [Related]

  • 37. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
    Fridrich L, Messa C, Landoni C, Lucignani G, Moncayo R, Kendler D, Riccabona G, Fazio F.
    Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694
    [Abstract] [Full Text] [Related]

  • 38. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 39. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
    Kohlfuerst S, Igerc I, Gallowitsch HJ, Gomez I, Kresnik E, Matschnig S, Lind P.
    Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338
    [Abstract] [Full Text] [Related]

  • 40. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D, Rubello D, Saladini G, Mazzarotto R, Sotti G, Tomasella G, Pelizzo MR.
    Tumori; 1999 Nov; 85(2):122-7. PubMed ID: 10363078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.